MitochondrialEmerging Evidence

MOTS-c

Also known as: Mitochondrial ORF of the 12S rRNA-c

Peptide encoded in mitochondrial DNA, studied for metabolism and exercise in animals.

Evidence

Emerging

FDA status

Not FDA-approved

Source

Mitochondrially-encoded peptide, synthesized therapeutically

Overview

Peptide encoded in mitochondrial DNA, studied for metabolism and exercise in animals.

Mechanism of Action

Activates FoxO transcription factors for stress resilience, enhances mitochondrial autophagy (mitophagy), promotes mitochondrial biogenesis, improves glucose and fat metabolism, increases insulin sensitivity, mimics caloric restriction pathways.

What research has looked at

Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.

  • Enhances metabolic efficiency
  • Improves insulin sensitivity
  • Promotes mitochondrial biogenesis
  • Aging pathways in animal models
  • Increases energy utilization
  • Supports exercise performance
  • Caloric-restriction-like effects in mice

Researched for

Research topics, not approved uses.

Metabolic syndromeType 2 diabetesObesityAge-related metabolic declineMitochondrial dysfunctionLow energy states

How Gabriel approaches peptides

MOTS-c can be requested through Gabriel. A licensed clinician at a telehealth partner reviews your request and decides whether it's appropriate. Gabriel never gives peptide dosing.

Compounded medications aren't FDA-approved. A licensed clinician decides what's right for you.

Read the peptide therapy guide

Research & Evidence

Evidence Level
Emerging
Studies

Animal studies, human observational data

Summary

Metabolic effects are reported in mice. Human data are limited to measuring natural MOTS-c levels; there are no controlled trials of taking it.

Safety Information

Potential Side Effects

  • •Injection site reactions
  • •Transient fatigue

Contraindications

  • Pregnancy
  • Breastfeeding

Interactions

  • ⚠May enhance metformin effects

Quick Facts

CategoryMitochondrial
SourceMitochondrially-encoded peptide, synthesized therapeutically
StatusNot FDA-approved; FDA has reviewed it as a nominated compounding substance